Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2

Predictive clinical factors associated with favorable responses to BNT162b2 mRNA vaccine against SARS-CoV-2 have been reported in some studies; however, there is a subgroup with low antibody titers without well-known clinical factors reducing antibody responses. To clarify the immunological backgrou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kageyama, Takahiro, Tanaka, Shigeru, Etori, Keishi, Hattori, Koto, Miyachi, Kazusa, Kasuya, Tadamichi, Iwamoto, Taro, Ikeda, Kei, Igari, Hidetoshi, Yokote, Koutaro, Nakajima, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872843/
https://www.ncbi.nlm.nih.gov/pubmed/35241300
http://dx.doi.org/10.1016/j.vaccine.2022.02.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872843/
https://www.ncbi.nlm.nih.gov/pubmed/35241300
http://dx.doi.org/10.1016/j.vaccine.2022.02.045

Ejemplares similares